Midyear Report 2022

— Financial reporting — Consolidated statement of changes in equity

Consolidated statement of changes in equity

January 1 – June 30

 

 

 

 

Attributable to shareholders of medmix Ltd

 

millions of CHF

 

Notes

 

Share capital

 

Retained earnings

 

Treasury shares

 

Cash flow hedge reserve

 

Currency translation adjustment

 

Total equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2021

 

 

 

 

345.7

 

 

 

–12.3

 

333.4

 

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

22.7

 

 

 

 

 

 

 

22.7

 

– Cash flow hedges, net of tax

 

 

 

 

 

 

–0.5

 

 

–0.5

 

– Remeasurements of defined benefit plans, net of tax

 

 

 

 

4.5

 

 

 

 

4.5

 

– Currency translation differences

 

 

 

 

 

 

 

10.5

 

10.5

 

Other comprehensive income

 

 

 

 

4.5

 

 

–0.5

 

10.5

 

14.5

 

Total comprehensive income for the period

 

 

 

 

27.3

 

 

–0.5

 

10.5

 

37.2

 

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contribution to the Sulzer group

 

8

 

 

–95.8

 

 

 

 

–95.8

 

Share-based payments

 

 

 

 

0.4

 

 

 

 

0.4

 

Dividends

 

8

 

 

–41.3

 

 

 

 

–41.3

 

Equity as of June 30, 2021

 

 

 

 

236.4

 

 

–0.5

 

–1.8

 

234.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2022

 

 

 

0.4

 

552.8

 

–6.5

 

–0.6

 

–12.2

 

533.9

 

Comprehensive income for the period:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

23.8

 

 

 

 

 

 

 

23.8

 

– Cash flow hedges, net of tax

 

 

 

 

 

 

–0.5

 

 

–0.5

 

– Remeasurements of defined benefit plans, net of tax

 

 

 

 

–5.4

 

 

 

 

–5.4

 

– Currency translation differences

 

 

 

 

 

 

 

–8.0

 

–8.0

 

Other comprehensive income

 

 

 

 

–5.4

 

 

–0.5

 

–8.0

 

–13.9

 

Total comprehensive income for the period

 

 

 

 

18.4

 

 

–0.5

 

–8.0

 

9.9

 

Transactions with owners of the company:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contribution to the Sulzer group

 

8

 

 

–0.4

 

 

 

 

–0.4

 

Purchase of treasury shares

 

8

 

 

 

–6.1

 

 

 

–6.1

 

Share-based payments

 

 

 

 

0.8

 

 

 

 

0.8

 

Dividends

 

8

 

 

–20.5

 

 

 

 

–20.5

 

Equity as of June 30, 2022

 

 

 

0.4

 

551.0

 

–12.5

 

–1.0

 

–20.3

 

517.6